Nanoemulsions prepared from mountain ginseng-mediated gold nanoparticles and silydianin increase the anti-inflammatory effects by regulating NF-κB and MAPK signaling pathways
Source abstract
Abstract
In order to increase the bioavailability of mountain ginseng (MG), gold nanoparticles (MG-AuNPs) were biologically synthesized from MG extract, and an oil-in-water (O/W) nanoemulsion (SMG-AuNEs) was prepared from MG-AuNPs and a phytochemical silydianin. The physical stability of SMG-AuNEs were monitored and optimized in terms of particle size, pH value, zeta potential, and polydispersity index. The chemicostructural properties of the prepared MG-AuNPs and SMG-AuNEs were characterized using various spectrometric and microscopic analyses, such as EDX spectroscopy, FT-IR spectroscopy, and TEM. The effect of both nanomaterial samples on the anti-inflammatory activity and their underlying mechanism was compared in LPS-stimulated RAW 264.7 cells. SMG-AuNEs did not show toxic effects against RAW 264.7 macrophages, HaCaT keratinocytes, and normal dermal fibroblasts. SMG-AuNEs exhibited significantly higher inhibition of pro-inflammatory genes and proteins, including IL-1β, IL-6, and TNF-α, compared with those of MG-AuNPs and silydianin. Western blotting analysis revealed that the MAPK and NF-κB signalings were highly inhibited by SMG-AuNEs treatment. Hence, this study shows that nano-emulsification of gold nanoparticles prepared from MG is a useful method for augmenting the anti-inflammatory potential of MG. This study may serve as a foundation for using MG as a functional ingredient in anti-inflammatory agents. Our results may implicate the use of nanoemulsions to develop new anti-inflammatory products using MG.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Ginseng Biological Effects and Applications · Natural product bioactivities and synthesis · Pharmacological Effects of Natural Compounds
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Ginseng, the 'immunity boost': the effects of Panax ginseng on immune system10.5142/jgr.2012.36.4.354 ↗
2. Role of ginsenosides, the main active components of Panax ginseng, in inflammatory responses and diseases10.1016/j.jgr.2016.08.004 ↗
3. Endophytic trichoderma citrinoviride isolated from mountain-cultivated ginseng (Panax ginseng) has great potential as a biocontrol agent against ginseng pathogens10.1016/j.jgr.2018.03.002 ↗
4. Remarkable impact of steam temperature on ginsenosides transformation from fresh ginseng to red ginseng10.1016/j.jgr.2017.02.003 ↗
5. Identification of mountain-cultivated ginseng and cultivated ginseng using UPLC/oa-TOF MSE with a multivariate statistical sample-profiling strategy10.1016/j.jgr.2015.11.001 ↗
6. Anticancer effect of mountain ginseng on human breast cancer: comparison with farm-cultivated ginseng10.1155/2020/2584783 ↗
7. The characteristics of ginsenosides and oligosaccharides in mountain- and garden-cultivated ginseng10.1002/jsfa.10762 ↗
8. Identification and analysis of differentially expressed genes in mountain cultivated ginseng and mountain wild ginseng10.1016/S2005-2901(11)60018-6 ↗
9. Comparative transcriptome analyses on terpenoids metabolism in field- and mountain-cultivated ginseng roots10.1186/s12870-019-1682-5 ↗
10. Peptides as potential biomarkers for authentication of mountain-cultivated ginseng and cultivated ginseng of different ages using UPLC-HRMS10.1021/acs.jafc.9b05568 ↗
11. The bioavailability of red ginseng extract fermented by phellinus linteus10.5142/jgr.2013.37.108 ↗
12. Metabolism of ginseng and its interactions with drugs10.2174/138920011797470128 ↗
13. Degradation of ginsenosides in humans after oral administration10.1124/dmd.31.8.1065 ↗
14. Recent trends of nano bioactive compounds from ginseng for its possible preventive role in chronic disease models10.1039/C5RA20559J ↗
15. Ginseng nanoparticles: a budding tool for cancer treatment10.2217/nnm-2017-0070 ↗
16. Green synthesis of metallic nanoparticles via biological entities10.3390/ma8115377 ↗
17. Stability and controlled release of lutein loaded in zein nanoparticles with and without lecithin and pluronic F127 surfactants10.1016/j.colsurfa.2016.04.038 ↗
18. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth10.1186/s40425-019-0817-4 ↗
19. "Nano-Ginseng" for enhanced cytotoxicity against cancer cells10.3390/ijms19020627 ↗
20. Gold nanoparticles synthesized using Panax ginseng leaves suppress inflammatory - mediators production via blockade of NF-κB activation in macrophages10.1080/21691401.2016.1228661 ↗
21. Use of gold nanoparticle fertilizer enhances the ginsenoside contents and anti-inflammatory effects of red ginseng10.4014/jmb.1604.04034 ↗
22. Ginseng-berry-mediated gold and silver nanoparticle synthesis and evaluation of their in vitro antioxidant, antimicrobial, and cytotoxicity effects on human dermal fibroblast and murine melanoma skin cell lines10.2147/IJN.S118373 ↗
23. Ultra-sonication-assisted silver nanoparticles using Panax ginseng root extract and their anti-cancer and antiviral activities10.1016/j.jphotobiol.2018.08.013 ↗
24. Gold nanoparticles synthesized with fresh Panax ginseng leaf extract suppress adipogenesis by downregulating PPARγ/CEBPα signaling in 3T3-L1 mature adipocytes10.1166/jnn.2019.15753 ↗
25. Fabrication of fluorescent labeled ginseng polysaccharide nanoparticles for bioimaging and their immunomodulatory activity on macrophage cell lines10.1016/j.ijbiomac.2017.12.050 ↗
26. Biosynthesis of gold nanoparticles using Nigella sativa and curtobacterium proimmune K3 and evaluation of their anticancer activity10.1016/j.msec.2021.112214 ↗
27. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method10.1006/meth.2001.1262 ↗
28. Nano-emulsions: formation by low-energy methods10.1016/j.cocis.2012.07.003 ↗
29. Optimization of isothermal low-energy nanoemulsion formation: hydrocarbon oil, non-ionic surfactant, and water systems10.1016/j.jcis.2014.03.035 ↗
30. Rotation and migration of nanoparticles for heat transfer augmentation in nanofluids by molecular dynamics simulation10.1016/j.csite.2015.10.003 ↗
31. Formation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessments10.1186/1477-3155-9-44 ↗
32. Green synthesis of multifunctional silver and gold nanoparticles from the oriental herbal adaptogen: siberian ginseng10.2147/IJN.S108549 ↗
33. HaCaT keratinocytes response on antimicrobial atelocollagen substrates: extent of cytotoxicity, cell viability and proliferation10.3390/jfb5020043 ↗
34. Nitric oxide in health and disease of the nervous system10.1089/ars.2008.2234 ↗
35. Inducible nitric oxide synthase: regulation, structure, and inhibition10.1002/med.21599 ↗
36. Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases10.2174/0929867325666180514112124 ↗
37. Reactive oxygen species in inflammation and tissue injury10.1089/ars.2012.5149 ↗
38. Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264.7 macrophages10.1016/j.foodchem.2011.07.049 ↗
39. Cytokines, inflammation, and pain10.1097/AIA.0b013e318034194e ↗
40. Hall of fame among pro-inflammatory cytokines: Interleukin-6 gene and its transcriptional regulation mechanisms10.3389/fimmu.2016.00604 ↗
41. NF-κB signaling in inflammation10.1038/sigtrans.2017.23 ↗
42. MAPK signalling pathways as molecular targets for anti-inflammatory therapy–from molecular mechanisms to therapeutic benefits10.1016/j.bbapap.2005.08.017 ↗
43. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kB dependent10.1046/j.1523-1755.2000.00051.x ↗
44. Autoregulation of I kappa B alpha activity10.1073/pnas.91.1.28 ↗
45. IkappaB kinases: key regulators of the NF-kappaB pathway10.1016/j.tibs.2003.12.003 ↗
46. Signalling pathways of the TNF superfamily: a double-edged sword10.1038/nri1184 ↗
47. NF-kappaB: a key role in inflammatory diseases10.1172/JCI11830 ↗
48. The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS